白芍总苷胶囊联合西药治疗活动期类风湿关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R593.22

基金项目:


Clinical Study on Treatment of Active Rheumatoid Arthritis with Total Glycosides of White Paeony Capsules Combined with Western Medicine
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察白芍总苷胶囊联合西药治疗活动期类风湿关节炎的疗效及对血清炎症因子、心肌酶谱 的影响。方法:选择2022年1月—2023年6月淳安县第一人民医院接诊的92例活动期类风湿关节炎患者为研 究对象,运用随机单双数法分为研究组和对照组各46例。对照组采用甲氨蝶呤片、来氟米特片及硫酸羟氯喹 片治疗,研究组在对照组基础上给予白芍总苷胶囊治疗。2组均治疗半年。比较2组治疗前后关节疼痛指数、 关节压痛指数、关节肿胀指数、晨僵持续时间、类风湿因子(RF)、红细胞沉降率(ESR),血清炎症因子[白 细胞介素-1(IL-1)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)],心肌酶谱 指标[谷草转氨酶(AST)、乳酸脱氢酶(LHD)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)] 及生活质量 量表(QOL)、日常生活工作能力量表(ADL) 评分;比较2组临床疗效及不良反应。结果:研究组总有效率 97.83%(45/46),高于对照组82.61%(38/46)(P<0.05)。治疗后,2组关节疼痛指数、关节压痛指数、关节 肿胀指数、RF及ESR均降低(P<0.05),且研究组低于对照组(P<0.05),2组晨僵持续时间均缩短(P< 0.05),且研究组短于对照组(P<0.05)。治疗后,2组IL-1、IL-6、TNF-α、CRP、AST、LHD、CK、CK-MB 水平均降低(P<0.05),且研究组低于对照组(P<0.05)。治疗后,2组QOL、ADL评分均升高(P<0.05), 且研究组高于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:白芍总苷 胶囊联合甲氨蝶呤片、来氟米特片治疗活动期类风湿关节炎疗效显著,能明显改善血清炎症因子及心肌酶谱水 平,且不增加不良反应。

    Abstract:

    Abstract:Objective:To observe the therapeutic effect of Total Glycosides of White Paeony Capsules combined with western medicine on active rheumatoid arthritis and its impact on serum inflammatory factors and myocardial enzyme spectrum. Methods: A total of 92 patients with active rheumatoid arthritis admitted to Chun'an First People's Hospital from January 2022 to June 2023 were selected as research subjects and divided into the study group and the control group,each with 46 cases,using the random odd-even number method. The control group was treated with Methotrexate Tablets, Leflunomide Tablets, and Hydroxychloroquine Sulfate Tablets, and the study group was additionally treated with Total Glycosides of White Paeony Capsules based on the control group. Both groups were treated for six months. The joint pain indexes,joint tenderness indexes,joint swelling indexes,duration of morning stiffness, rheumatoid factor (RF),erythrocyte sedimentation rate (ESR),serum inflammatory factors [interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor- α (TNF- α), and C-reactive protein (CRP)], myocardial enzyme spectrum indicators [aspartate aminotransferase (AST), lactate dehydrogenase (LHD), creatine kinase (CK), and creatine kinase isoenzyme (CK-MB)], and the scores of Quality of Life scale (QOL) and Activities of Daily Living scale( ADL) were compared before and after treatment between the two groups. The clinical effects and adverse reactions were also compared between the two groups. Results:The total effective rate in the study group was 97.83% (45/46), which was higher than that of 82.61% (38/46) in the control group (P<0.05). After treatment, the joint pain indexes, joint tenderness indexes, joint swelling indexes, RF, and ESR in both groups were declined (P<0.05), with the study group showing lower levels than the control group (P<0.05). The duration of morning stiffness was shortened in both groups (P<0.05),with the study group having a shorter duration than the control group (P<0.05). After treatment, the levels of IL-1, IL-6, TNF-α, CRP, AST, LHD, CK, and CK-MB in both groups were decreased (P<0.05),with the study group showing lower levels than the control group (P<0.05). The QOL and ADL scores in the two groups were increased (P<0.05), with the study group having higher scores than the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: The combination of Total Glycosides of White Paeony Capsules with Methotrexate Tablets and Leflunomide Tablets shows significant therapeutic effects on active rheumatoid arthritis. Without increasing adverse reactions,it can significantly improve serum inflammatory factors and myocardial enzyme spectrum levels.

    参考文献
    相似文献
    引证文献
引用本文

姜国英,陈道挺.白芍总苷胶囊联合西药治疗活动期类风湿关节炎临床研究[J].新中医,2025,57(9):72-77

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-05-12
  • 出版日期:
文章二维码